← Open Payments lookup

KATHRYN SHIRLEY: Open Payments

NPI 1639500465 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$686 in 23 payments from 14 companies in 2025. Trend: 2023 $2,699 · 2024 $2,098 · 2025 $686

Food & beverage: $606Education: $80
CompanyPaymentsAmount
Stemline Therapeutics Inc.2$148
Merck Sharp & Dohme LLC4$97
Janssen Biotech, Inc.2$95
GENZYME CORPORATION2$62
AstraZeneca Pharmaceuticals LP2$61
ABBVIE INC.2$52
Celgene Corporation2$40
Incyte Corporation1$25
PFIZER INC.1$21
Blueprint Medicines Corporation1$19

Products named: Orserdu, KEYTRUDA, DARZALEX, OPDIVO, LYNPARZA, QFITLIA, EPKINLY, SARCLISA.

Industry payments across TX — which companies pay providers there.